NeuroPace Inc

NPCE · XNAS

CIK 1528287fmd_01F6HSQRFPN9RJAR11EEWN5HAEManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods

Income Statement · Annual · Millions · USD
Line item	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	41	45	46	65	80	100
Cost of revenue	11	12	13	17	21	23
Gross profit	30	33	32	48	59	77
Research and development	16	18	22	21	24	28
Selling, general and administrative	28	39	51	55	57	66
Total operating expenses	43	57	73	75	81	94
Operating income	(13)	(24)	(41)	(27)	(22)	(16)
Interest expense	11	7	8	9	9	7
Interest and investment income	0	0	2	3	3	3
Other non-operating income (expense)	0	(5)	(0)	(0)	0	(0)
Income tax expense	–	–	–	–	–	0
Net income	(24)	(36)	(47)	(33)	(27)	(21)
Net income to common shareholders	(24)	(36)	(47)	(33)	(27)	(21)